"Genetic Markers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event.
| Descriptor ID |
D005819
|
| MeSH Number(s) |
D23.101.387 G05.695.450
|
| Concept/Terms |
Genetic Markers- Genetic Markers
- Markers, Genetic
- Genetic Marker
- Marker, Genetic
Chromosome Markers- Chromosome Markers
- Chromosome Marker
- Marker, Chromosome
- Markers, Chromosome
|
Below are MeSH descriptors whose meaning is more general than "Genetic Markers".
Below are MeSH descriptors whose meaning is more specific than "Genetic Markers".
This graph shows the total number of publications written about "Genetic Markers" by people in this website by year, and whether "Genetic Markers" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 43 | 44 |
| 1996 | 6 | 43 | 49 |
| 1997 | 5 | 54 | 59 |
| 1998 | 3 | 50 | 53 |
| 1999 | 4 | 48 | 52 |
| 2000 | 3 | 43 | 46 |
| 2001 | 4 | 53 | 57 |
| 2002 | 10 | 42 | 52 |
| 2003 | 7 | 48 | 55 |
| 2004 | 9 | 53 | 62 |
| 2005 | 10 | 57 | 67 |
| 2006 | 8 | 60 | 68 |
| 2007 | 7 | 58 | 65 |
| 2008 | 18 | 59 | 77 |
| 2009 | 5 | 48 | 53 |
| 2010 | 7 | 44 | 51 |
| 2011 | 5 | 37 | 42 |
| 2012 | 9 | 49 | 58 |
| 2013 | 7 | 33 | 40 |
| 2014 | 9 | 45 | 54 |
| 2015 | 10 | 49 | 59 |
| 2016 | 13 | 38 | 51 |
| 2017 | 9 | 33 | 42 |
| 2018 | 5 | 28 | 33 |
| 2019 | 10 | 23 | 33 |
| 2020 | 12 | 12 | 24 |
| 2021 | 4 | 11 | 15 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 1 | 1 |
| 2025 | 0 | 1 | 1 |
Below are the most recent publications written about "Genetic Markers" by people in Profiles.
-
DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children's Oncology Group. Clin Cancer Res. 2025 Mar 03; 31(5):890-898.
-
Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21 phenotypes. J Clin Invest. 2024 Jun 03; 134(11).
-
Multi-tissue epigenetic analysis identifies distinct associations underlying insulin resistance and Alzheimer's disease at CPT1A locus. Clin Epigenetics. 2023 10 27; 15(1):173.
-
Identification of a novel partial deletion of STS associated with pre-Descemet corneal dystrophy and X-linked ichthyosis. Mol Vis. 2023; 29:25-30.
-
Genome-wide analysis facilitates estimation of the amount of male contribution in meiotic gynogenetic three-spined stickleback (Gasterosteus aculeatus). J Fish Biol. 2023 Apr; 102(4):844-855.
-
Evaluation of cross-platform compatibility of a DNA methylation-based glucocorticoid response biomarker. Clin Epigenetics. 2022 10 28; 14(1):136.
-
Characteristics of community-acquired carbapenem-resistant Enterobacterales. J Antimicrob Chemother. 2022 09 30; 77(10):2763-2771.
-
A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events. Clin Epigenetics. 2022 09 29; 14(1):121.
-
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer. Nature. 2022 08; 608(7921):199-208.
-
Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinoma. Eur J Cancer. 2022 06; 168:68-76.